346
Views
40
CrossRef citations to date
0
Altmetric
Article

A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints

, , , ORCID Icon & ORCID Icon
Pages 1148-1165 | Received 11 Feb 2018, Accepted 20 Jul 2018, Published online: 05 Sep 2018

References

  • Bates, M. E., S. Larkin, J. M. Keisler, and I. Linkov. 2015. “How Decision Analysis Can Further Nanoinformatics.” Beilstein Journal of Nanotechnology 6 (1): 1594–600. doi:10.3762/bjnano.6.162.
  • Berthold, M. R., N. Cebron, F. Dill, T. R. Gabriel, T. Kötter, T. Meinl, P. Ohl, K. Thiel, and B. Wiswedel. 2009. “KNIME - the Konstanz Information Miner.” Acm Sigkdd Explorations Newsletter 11 (1): 26–31. doi:10.1145/1656274.1656280.
  • Bigdeli, A., S. Palchetti, D. Pozzi, M. R. Hormozi-Nezhad, F. Baldelli Bombelli, G. Caracciolo, and M. Mahmoudi. 2016. “Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties.” ACS Nano 10 (3): 3723–3737. doi:10.1021/acsnano.6b00261.
  • Cedervall, T., I. Lynch, S. Lindman, T. Berggård, E. Thulin, H. Nilsson, K. A. Dawson, and S. Linse. 2007. “Understanding the Nanoparticle-Protein Corona Using Methods to Quantify Exchange Rates and Affinities of Proteins for Nanoparticles.” Proceedings of the National Academy of Sciences of the United States of America 104 (7): 2050–2055. doi:10.1073/pnas.0608582104.
  • Fourches, D., and A. Tropsha 2014. “Quantitative Nanostructure-Activity Relationships: from unstructured data to predictive models for designing nanomaterials with controlled properties”, In Nanotoxicology: Progress toward nanomedicine, edited by N. A. Monteiro-Riviere Tran and C. Lang Tran, CRC Press.
  • Dobrovolskaia, M. A., B. W. Neun, S. Man, X. Ye, M. Hansen, A. K. Patri, R. M. Crist, and S. E. McNeil. 2014. “Protein Corona Composition Does Not Accurately Predict Hematocompatibility of Colloidal Gold Nanoparticles.” Nanomedicine: nanotechnology, Biology, and Medicine 10 (7): 1453–1463. doi:10.1016/j.nano.2014.01.009.
  • Farrera, C., and B. Fadeel. 2015. “It Takes Two to Tango: Understanding the Interactions between Engineered Nanomaterials and the Immune System.” European Journal of Pharmaceutics and Biopharmaceutics: official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V 95 (Pt A): 3–12. doi:10.1016/j.ejpb.2015.03.007.
  • Fjodorova, N., M. Novic, A. Gajewicz, and B. Rasulev. 2017. “The Way to Cover Prediction for Cytotoxicity for All Existing Nano-Sized Metal Oxides by Using Neural Network Method.” Nanotoxicology 11 (4): 475–83. doi:10.1080/17435390.2017.1310949.
  • Foroozandeh, P., and A. A. Aziz. 2015. “Merging Worlds of Nanomaterials and Biological Environment: Factors Governing Protein Corona Formation on Nanoparticles and Its Biological Consequences.” Nanoscale Research Letters 10 (1): 221. doi:10.1186/s11671-015-0922-3.
  • Fourches, D., D. Pu, L. Li, H. Zhou, Q. Mu, G. Su, B. Yan, and A. Tropsha. 2016. “Computer-Aided Design of Carbon Nanotubes with the Desired Bioactivity and Safety Profiles.” Nanotoxicology 10 (3): 374–383. doi:10.3109/17435390.2015.1073397.
  • Gajewicz, A., T. Puzyn, K. Odziomek, P. Urbaszek, A. Haase, C. Riebeling, A. Luch, et al. 2018. “Decision Tree Models to Classify Nanomaterials according to the DF4nanoGrouping Scheme.” Nanotoxicology. Taylor & Francis 12 (1): 1–17. doi:10.1080/17435390.2017.1415388.
  • García-Álvarez, R., M. Hadjidemetriou, A. Sánchez-Iglesias, L. M. Liz-Marzán, and K. Kostarelos. 2018. “In Vivo Formation of Protein Corona on Gold Nanoparticles. The Effect of Their Size and Shape.” Nanoscale 10 (3): 1256–1264. doi:10.1039/c7nr08322j.
  • Göppert, T. M., and R. H. Müller. 2005. “Adsorption Kinetics of Plasma Proteins on Solid Lipid Nanoparticles for Drug Targeting.” International Journal of Pharmaceutics 302 (1–2): 172–86. doi:10.1016/j.ijpharm.2005.06.025.
  • Haase, A., J. Tentschert, and A. Luch. 2012. “Nanomaterials: A Challenge for Toxicological Risk Assessment?” EXS. 10:219–250. doi: 10.1007/978-3-7643-8340-4_8.
  • Hadjidemetriou, M., and K. Kostarelos. 2017. “Nanomedicine: Evolution of the Nanoparticle Corona.” Nature Nanotechnology 12 (4): 288–290. doi:10.1038/nnano.2017.61.
  • Hall, M., E. Frank, G. Holmes, B. Pfahringer, P. Reutemann, and I. H. Witten. 2009. “The WEKA Data Mining Software: An Update.” ACM SIGKDD Explorations Newsletter 11 (1): 10–18. doi:10.1145/1656274.1656278.
  • Hu, Z., H. Zhang, Y. Zhang, R. Wu, and H. Zou. 2014. “Nanoparticle Size Matters in the Formation of Plasma Protein Coronas on Fe3O4 Nanoparticles.” Colloids and Surfaces. B, Biointerfaces 121:354–61. doi:10.1016/j.colsurfb.2014.06.016.
  • IHCP/2011/I/05/27/OC 2013. Examination and assessment of consequences for industry, consumers, human health and the environment of possible options for changing the REACH requirements for nanomaterials. Accessed 11 August 2018. http://ec.europa.eu/environment/chemicals/nanotech/pdf/Final_Report.pdf.
  • Isayev, O., C. Oses, C. Toher, E. Gossett, S. Curtarolo, and A. Tropsha. 2017. “Universal Fragment Descriptors for Predicting Properties of Inorganic Crystals.” Nature Communications 8:15679. doi:10.1038/ncomms15679.
  • Kar, S., A. Gajewicz, K. Roy, J. Leszczynski, and T. Puzyn. 2016. “Extrapolating between Toxicity Endpoints of Metal Oxide Nanoparticles: Predicting Toxicity to Escherichia coli and Human Keratinocyte Cell Line (HaCaT) with Nano-QTTR.” Ecotoxicology and Environmental Safety 126:238–244. doi:10.1016/j.ecoenv.2015.12.033.
  • Kleandrova, V. V., F. Luan, H. González-Díaz, J. M. Ruso, A. Speck-Planche, and M. N. D. S. Cordeiro. 2014. “Computational Tool for Risk Assessment of Nanomaterials: novel QSTR-Perturbation Model for Simultaneous Prediction of Ecotoxicity and Cytotoxicity of Uncoated and Coated Nanoparticles under Multiple Experimental Conditions.” Environmental Science & Technology 48 (24): 14686–14694. doi:10.1021/es503861x.
  • Lesniak, A., A. Salvati, M. J. Santos-Martinez, M. W. Radomski, K. A. Dawson, and C. Aberg. 2013. “Nanoparticle Adhesion to the Cell Membrane and Its Effect on Nanoparticle Uptake Efficiency.” Journal of the American Chemical Society 135 (4): 1438–1444. doi:10.1021/ja309812z.
  • Liu, H., X. Yao, and P. Gramatica. 2009. “The Applications of Machine Learning Algorithms in the Modeling of Estrogen-like Chemicals.” Combinatorial Chemistry & High Throughput Screening 12 (5): 490–496. doi:10.2174/138620709788489037.
  • Liu, R., W. Jiang, C. D. Walkey, W. C. W. Chan, and Y. Cohen. 2015. “Prediction of Nanoparticles-Cell Association Based on Corona Proteins and Physicochemical Properties.” Nanoscale 7 (21): 9664–9675. doi:10.1039/C5NR01537E.
  • Liu, R., R. Rallo, S. George, Z. Ji, S. Nair, A. E. Nel, and Y. Cohen. 2011. “Classification NanoSAR Development for Cytotoxicity of Metal Oxide Nanoparticles.” Small (Weinheim an Der Bergstrasse, Germany) 7 (8): 1118–1126. doi:10.1002/smll.201002366.
  • Lynch, I., A. Afantitis, G. Leonis, G. Melagraki, and E. Valsami-Jones. 2017. “Strategy for Identification of Nanomaterials’ Critical Properties Linked to Biological Impacts: Interlinking of Experimental and Computational Approaches”, In Advances in QSAR modeling., edited by Roy K., 385–424. Cham: Springer.
  • Lynch, I., K. A. Dawson, J. R. Lead, and E. Valsami-Jones. 2014. “Macromolecular Coronas and Their Importance in Nanotoxicology and Nanoecotoxicology.” In Frontiers of Nanoscience 7:127–156. doi:10.1016/B978-0-08-099408-6.00004-9.
  • Marvin, H. J. P., H. Bouwmeester, M. Bakker, E. D. Kroese, D. van de Meent, F. Bourgeois, R. Lokers, H. van der Ham, and L. Verhelst. 2013. “Exploring the Development of a Decision Support System (DSS) to Prioritize Engineered Nanoparticles for Risk Assessment.” Journal of Nanoparticle Research 15 (8): 1839. doi:10.1007/s11051-013-1839-3.
  • Melagraki, G., and A. Afantitis. 2013. “Enalos KNIME Nodes: Exploring Corrosion Inhibition of Steel in Acidic Medium.” Chemometrics and Intelligent Laboratory Systems 123:9. doi:10.1016/j.chemolab.2013.02.003.
  • Melagraki, G., and A. Afantitis. 2014. “Enalos InSilicoNano Platform: An Online Decision Support Tool for the Design and Virtual Screening of Nanoparticles.” RSC Adv 4 (92): 50713–50725. doi:10.1039/C4RA07756C.
  • Melagraki, G., and A. Afantitis. 2015. “A Risk Assessment Tool for the Virtual Screening of Metal Oxide Nanoparticles through Enalos Insiliconano Platform.” Current Topics in Medicinal Chemistry 15 (18): 1827–1836. doi:10.2174/1568026615666150506144536.
  • Melagraki, G., A. Afantitis, H. Sarimveis, P. A Koutentis, J. Markopoulos, and O. Igglessi-Markopoulou. 2006. “A Novel QSPR Model for Predicting θ (Lower Critical Solution Temperature) in Polymer Solutions Using Molecular Descriptors.” Journal of Molecular Modeling 13 (1): 55–64. doi:10.1007/s00894-006-0125-z.
  • Melagraki, G., E. Ntougkos, V. Rinotas, C. Papaneophytou, G. Leonis, T. Mavromoustakos, G. Kontopidis, E. Douni, A. Afantitis, and G. Kollias. 2017. “Cheminformatics-Aided Discovery of Small-Molecule Protein-Protein Interaction (PPI) Dual Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).” PLoS Computational Biology 13 (4): e1005372. doi:10.1371/journal.pcbi.1005372.
  • Mikolajczyk, A., A. Gajewicz, B. Rasulev, N. Schaeublin, E. Maurer-Gardner, S. Hussain, J. Leszczynski, and T. Puzyn. 2015. “Zeta Potential for Metal Oxide Nanoparticles: A Predictive Model Developed by a Nano-Quantitative Structure–Property Relationship Approach.” Chemistry of Materials 27 (7): 2400–2407. doi:10.1021/cm504406a.
  • Monopoli, M. P., C. Aberg, A. Salvati, and K. A. Dawson. 2012. “Biomolecular Coronas Provide the Biological Identity of Nanosized Materials.” Nature Nanotechnology 7 (12): 779–786. doi:10.1038/nnano.2012.207.
  • Mu, Y., F. Wu, Q. Zhao, R. Ji, Y. Qie, Y. Zhou, Y. Hu, C. Pang, D. Hristozov, J. P. Giesy, and B. Xing. 2016. “Predicting Toxic Potencies of metal oxide Nanoparticles by Means of Nano-QSARs.” Nanotoxicology 10 (9): 1207–1214. doi:10.1080/17435390.2016.1202352.
  • Nicola, G., M. R. Berthold, M. P. Hedrick, and M. K. Gilson. 2015. “Connecting Proteins with Drug-like Compounds: Open Source Drug Discovery Workflows with BindingDB and KNIME.” Database: The Journal of Biological Databases and Curation 2015:bav087. doi:10.1093/database/bav087.
  • NovaMechanics Ltd 2013. Enalos KNIME Nodes. Accessed 29 December 2017. http://enalosplus.novamechanics.com
  • NovaMechanics Ltd 2017. Enalos Cloud Platform. Accessed 29 December 2017. http://www.insilicotox.com/index.php/products/predictive-models-web-services
  • OECD 2007. Principles for the validation, for regulatory purposes of (Quantitative) Structure Activity Relationship Models. Accessed 11 August 2017. http://www.oecd.org/env/ehs/oecdquantitativestructure-activityrelationshipsprojectqsars.htm.
  • Petri, B., A. Bootz, A. Khalansky, T. Hekmatara, R. Müller, R. Uhl, J. Kreuter, and S. Gelperina. 2007. “Chemotherapy of Brain Tumour Using Doxorubicin Bound to Surfactant-Coated Poly(Butyl Cyanoacrylate) Nanoparticles: revisiting the Role of Surfactants.” Journal of Controlled Release: official Journal of the Controlled Release Society 117 (1): 51–58. doi:10.1016/j.jconrel.2006.10.015.
  • Pino, P.,. del Pelaz, B. Zhang, Q. Maffre, P. Nienhaus, G. U. Parak. and W. J. 2014. “Protein Corona Formation around Nanoparticles – from the past to the Future.” Mater. Horiz 1 (3): 301–313. doi:10.1039/C3MH00106G.
  • Puzyn, T., N. Jeliazkova, H. Sarimveis, R. L. Marchese Robinson, V. Lobaskin, R. Rallo, A.-N. Richarz, A. Gajewicz, M. G. Papadopulos, J. Hastings, M. T. D. Cronin, et al. 2017. “Perspectives from the NanoSafety Modelling Cluster on the Validation Criteria for (Q)SAR Models Used in Nanotechnology.” Food and Chemical Toxicology 112: 478–494. doi:10.1016/j.fct.2017.09.037.
  • Rallo, R., B. France, R. Liu, S. Nair, S. George, R. Damoiseaux, F. Giralt, A. Nel, K. Bradley, and Y. Cohen. 2011. “Self-Organizing Map Analysis of Toxicity-Related Cell Signaling Pathways for Metal and Metal Oxide Nanoparticles.” Environmental Science and Technology 45 (4): 1695–1702. doi:10.1021/es103606x.
  • Rasulev, B., A. Gajewicz, T. Puzyn, D. Leszczynska, and J. Leszczynski*. 2012. “Towards Efficient Designing of Safe Nanomaterials: Innovative Merge of Computational Approaches and Experimental Techniques.” Chapter 10 in Nano-QSAR: Advances and challenges, edited by Jerzy Leszczynski, Tomasz Puzyn, 220–256. Cambridge, UK: Royal Society of Chemistry.
  • Ritz, S., S. Schöttler, N. Kotman, G. Baier, A. Musyanovych, J. Kuharev, K. Landfester, H. Schild, O. Jahn, S. Tenzer, et al. 2015. “Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake.” Biomacromolecules 16 (4): 1311–21. doi:10.1021/acs.biomac.5b00108.
  • Roca, C. P., R. Rallo, A. Fernandez, and F. Giralt. 2012. “Nanoinformatics for Safe-by-Design Engineered Nanomaterials.” Chapter 6 in Towards efficient designing of safe nanomaterials: Innovative merge of computational approaches and experimental techniques, edited by Tomasz Puzyn and Jerzy Leszczynski, 89–107. Cambridge, UK: RSC Nanoscience & Nanotechnology.
  • Sakulkhu, U., M. Mahmoudi, L. Maurizi, J. Salaklang, and H. Hofmann. 2014. “Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings.” Scientific Reports 4 (1): 5020. doi:10.1038/srep05020.
  • Scieszka, J. F., L. L. Maggiora, S. D. Wright, and M. J. Cho. 1991. “Role of Complements C3 and C5 in the Phagocytosis of Liposomes by Human Neutrophils.” Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists 8 (1): 65–69. doi:10.1023/A:1015830306839.
  • Sempf, K., T. Arrey, S. Gelperina, T. Schorge, B. Meyer, M. Karas, and J. Kreuter. 2013. “Adsorption of Plasma Proteins on Uncoated PLGA Nanoparticles.” European Journal of Pharmaceutics and Biopharmaceutics: official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V 85 (1): 53–60. doi:10.1016/j.ejpb.2012.11.030.
  • Shannahan, J. H., X. Lai, P. C. Ke, R. Podila, J. M. Brown, and F. A. Witzmann. 2013. “Silver Nanoparticle Protein Corona Composition in Cell Culture Media.” PLoS One 8 (9): e74001. doi:10.1371/journal.pone.0074001.
  • Speck-Planche, A., V. V. Kleandrova, F. Luan, and M. N. D. S. Cordeiro. 2015. “Computational Modeling in Nanomedicine: prediction of Multiple Antibacterial Profiles of Nanoparticles Using a Quantitative Structure-Activity Relationship Perturbation Model.” Nanomedicine (London, England) 10 (2): 193–204. doi:10.2217/nnm.14.96.
  • Steinmetz, F. P., C. L. Mellor, T. Meinl, and M. T. D. Cronin. 2015. “Screening Chemicals for Receptor-Mediated Toxicological and Pharmacological Endpoints: Using Public Data to Build Screening Tools within a KNIME Workflow.” Molecular Informatics 34 (2–3): 171–178. doi:10.1002/minf.201400188.
  • Stigler, J., M. Lundqvist, T. Cedervall, K. Dawson, and I. Lynch. 2010. “Protein Interactions with Microballoons: Consequences for Biocompatibility and Application as Contrast Agents” In Ultrasound contrast agents, edited by Paradossi G., P. Pellegretti, and A. Trucco, 53–66. Milano: Springer Milan.
  • Tämm, K., L. Sikk, J. Burk, R. Rallo, S. Pokhrel, L. Mädler, J. J. Scott-Fordsmand, P. Burk, and T. Tamm. 2016. “Parametrization of Nanoparticles: development of Full-Particle Nanodescriptors.” Nanoscale 8 (36): 16243–16250. doi:10.1039/C6NR04376C.
  • Tantra, R., C. Oksel, T. Puzyn, J. Wang, K. N. Robinson, X. Z. Wang, C. Y. Ma, and T. Wilkins. 2015. “Nano(Q)SAR: Challenges, Pitfalls and Perspectives.” Nanotoxicology 9 (5): 636–642. doi:10.3109/17435390.2014.952698.
  • Toropova, A. P., A. A. Toropov, D. Leszczynska, and J. Leszczynski. 2017. “CORAL and Nano-QFAR: Quantitative Feature – Activity Relationships (QFAR) for Bioavailability of Nanoparticles (ZnO, CuO, Co3O4, and TiO2).” Ecotoxicology and Environmental Safety 139:404–407. doi:10.1016/j.ecoenv.2017.01.054.
  • Treuel, L., S. Brandholt, P. Maffre, S. Wiegele, L. Shang, and G. U. Nienhaus. 2014. “Impact of Protein Modification on the Protein Corona on Nanoparticles and Nanoparticle-Cell Interactions.” ACS Nano 8 (1): 503–513. doi:10.1021/nn405019v.
  • Tropsha, A., K. C. Mills, and A. J. Hickey. 2017. “Reproducibility, Sharing and Progress in Nanomaterial Databases.” Nature Nanotechnology 12 (12): 1111–1114. doi:10.1038/nnano.2017.233.
  • Varnamkhasti, B. S., H. Hosseinzadeh, M. Azhdarzadeh, S. Y. Vafaei, M. Esfandyari-Manesh, Z. H. Mirzaie, M. Amini, S. N. Ostad, F. Atyabi, and R. Dinarvand. 2015. “Protein Corona Hampers Targeting Potential of MUC1 Aptamer Functionalized SN-38 Core-Shell Nanoparticles.” International Journal of Pharmaceutics 494 (1): 430–444. doi:10.1016/j.ijpharm.2015.08.060.
  • Varsou, D. D., G. Melagraki, H. Sarimveis, and A. Afantitis. 2017. “MouseTox: An Online Toxicity Assessment Tool for Small Molecules through Enalos Cloud Platform.” Food and Chemical Toxicology 110:83–93. doi:10.1016/j.fct.2017.09.058.
  • Vilanova, O., J. J. Mittag, P. M. Kelly, S. Milani, K. A. Dawson, J. O. Rädler, and G. Franzese. 2016. “Understanding the Kinetics of Protein-Nanoparticle Corona Formation.” ACS Nano 10 (12): 10842–10850. doi:10.1021/acsnano.6b04858.
  • Vrontaki, E., T. Mavromoustakos, G. Melagraki, and A. Afantitis. 2016. “Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterials”. Pharmaceutical sciences. 1314–1338. doi: 10.4018/978-1-5225-1762-7.ch050.
  • Vrontaki, E., G. Melagraki, T. Mavromoustakos, and A. Afantitis. 2015. “Exploiting ChEMBL Database to Identify Indole Analogs as HCV Replication Inhibitors.” Methods (San Diego, Calif.) 71 (C): 4–13. doi:10.1016/j.ymeth.2014.03.021.
  • Walkey, C. D., J. B. Olsen, F. Song, R. Liu, H. Guo, D. W. H. Olsen, Y. Cohen, A. Emili, and W. C. W. Chan. 2014. “Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles.” ACS Nano. American Chemical Society 8 (3): 2439–2455. doi:10.1021/nn406018q.
  • Winkler, D. A. 2016. “Recent Advances, and Unresolved Issues, in the Application of Computational Modelling to the Prediction of the Biological Effects of Nanomaterials.” Toxicology and Applied Pharmacology 299:96–100. doi:10.1016/j.taap.2015.12.016.
  • Witten, I. H., E. Frank, and M. A. Hall. 2011. “Data Mining: Practical Machine Learning Tools and Techniques.” Third Edition, Annals of Physics. Morgan Kaufmann, Cambridge, USA (an imprint of Elsevier). doi:10.1002/1521-3773(20010316)40:6 < 9823::AID-ANIE9823 > 3.3.CO;2-C.
  • Yin, Z. Ji, T. Xia, H. Meng, C. Low-Kam, R. Liu, S. Pokhrel, S. Lin, X. Wang, Y.-P. Liao. 2015. “Quantitative Regression Models for the Prediction of Chemical Properties by an Efficient Workflow.” Molecular Informatics 34 (10): 679–688. doi:10.1002/minf.201400119.
  • Zhang, H., Ji, Z. Xia, T. Meng, H. Low-Kam, C. Liu, R. Pokhrel, S. Lin, S. Wang, X. Liao. Y.-P. et al. 2012. “Use of Metal Oxide Nanoparticle Band Gap to Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation.” ACS Nano 6 (5): 4349–4368. doi: doi:10.1021/nn3010087.
  • Zhang, S., A. Golbraikh, S. Oloff, H. Kohn, and A. Tropsha. 2006. “A Novel Automated Lazy Learning QSAR (ALL-QSAR) Approach: Method Development, Applications, and Virtual Screening of Chemical Databases Using Validated ALL-QSAR Models.” Journal of Chemical Information and Modeling 46 (5): 1984–1995. doi:10.1021/ci060132x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.